Deciphera Pharmaceuticals, Inc.
NASDAQ:DCPH
25.59 (USD) • At close June 10, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 163.356 | 134.036 | 96.148 | 42.087 | 25 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 3.732 | 8.77 | 2.932 | 0.225 | 0.83 | 0 | 0 | 0 | 0 |
| Gross Profit
| 159.624 | 125.266 | 93.216 | 41.862 | 24.17 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.977 | 0.935 | 0.97 | 0.995 | 0.967 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 234.123 | 187.821 | 257.04 | 198.97 | 157.61 | 82.887 | 39.514 | 20.163 | 12.475 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 21.212 | 11.421 | 5.675 | 5.135 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 136.459 | 120.167 | 136.253 | 114.082 | 68.116 | 21.212 | 11.421 | 5.675 | 5.135 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.004 | 0 |
| Operating Expenses
| 370.582 | 307.988 | 393.293 | 313.052 | 225.726 | 104.099 | 50.935 | 25.838 | 17.61 |
| Operating Income
| -210.958 | -182.722 | -300.077 | -271.19 | -200.726 | -104.099 | -50.935 | -25.838 | -17.61 |
| Operating Income Ratio
| -1.291 | -1.363 | -3.121 | -6.444 | -8.029 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 16.447 | 4.513 | 0.113 | 4.701 | 8.47 | 4.245 | 0.651 | 0.004 | -2.206 |
| Income Before Tax
| -194.511 | -178.209 | -299.964 | -266.489 | -192.256 | -99.854 | -50.284 | -25.94 | -19.816 |
| Income Before Tax Ratio
| -1.191 | -1.33 | -3.12 | -6.332 | -7.69 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.431 | 0.722 | -3.127 | 0 | -0.763 | 4.329 | 0.746 | 0.11 | 0.003 |
| Net Income
| -194.942 | -178.931 | -296.837 | -266.489 | -191.493 | -99.854 | -50.284 | -25.94 | -19.816 |
| Net Income Ratio
| -1.193 | -1.335 | -3.087 | -6.332 | -7.66 | 0 | 0 | 0 | 0 |
| EPS
| -2.29 | -2.37 | -5.11 | -4.78 | -4.47 | -2.82 | -2.99 | -1.24 | -0.95 |
| EPS Diluted
| -2.29 | -2.37 | -5.11 | -4.78 | -4.47 | -2.82 | -2.99 | -1.24 | -0.95 |
| EBITDA
| -208.858 | -182.722 | -300.077 | -264.184 | -192.189 | -99.77 | -50.039 | -25.744 | -17.534 |
| EBITDA Ratio
| -1.279 | -1.363 | -3.121 | -6.277 | -7.688 | 0 | 0 | 0 | 0 |